Arthur F. Ryan - 01 Mar 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
01 Mar 2022
Net transactions value
-$61,837
Form type
4
Filing time
03 Mar 2022, 15:19:39 UTC
Previous filing
02 Feb 2022
Next filing
04 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $1,822 -3 -0.01% $607.28 22,479 01 Mar 2022 Direct F1, F2
transaction REGN Common Stock Sale $1,217 -2 -0.01% $608.48 22,477 01 Mar 2022 Direct F1, F3
transaction REGN Common Stock Sale $1,829 -3 -0.01% $609.61 22,474 01 Mar 2022 Direct F1, F4
transaction REGN Common Stock Sale $1,832 -3 -0.01% $610.83 22,471 01 Mar 2022 Direct F1, F5
transaction REGN Common Stock Sale $1,833 -3 -0.01% $611.04 22,468 01 Mar 2022 Direct F1, F6
transaction REGN Common Stock Sale $1,837 -3 -0.01% $612.45 22,465 01 Mar 2022 Direct F1, F7
transaction REGN Common Stock Sale $1,228 -2 -0.01% $613.82 22,463 01 Mar 2022 Direct F1
transaction REGN Common Stock Sale $2,458 -4 -0.02% $614.38 22,459 01 Mar 2022 Direct F1, F8
transaction REGN Common Stock Sale $1,846 -3 -0.01% $615.45 22,456 01 Mar 2022 Direct F1, F9
transaction REGN Common Stock Sale $4,316 -7 -0.03% $616.55 22,449 01 Mar 2022 Direct F1, F10
transaction REGN Common Stock Sale $5,559 -9 -0.04% $617.66 22,440 01 Mar 2022 Direct F1, F11
transaction REGN Common Stock Sale $1,855 -3 -0.01% $618.34 22,437 01 Mar 2022 Direct F1, F12
transaction REGN Common Stock Sale $4,336 -7 -0.03% $619.40 22,430 01 Mar 2022 Direct F1, F13
transaction REGN Common Stock Sale $3,723 -6 -0.03% $620.55 22,424 01 Mar 2022 Direct F1, F14
transaction REGN Common Stock Sale $4,971 -8 -0.04% $621.43 22,416 01 Mar 2022 Direct F1, F15
transaction REGN Common Stock Sale $13,072 -21 -0.09% $622.49 22,395 01 Mar 2022 Direct F1, F16
transaction REGN Common Stock Sale $8,102 -13 -0.06% $623.23 22,382 01 Mar 2022 Direct F1, F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $607.00 to $607.42. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 2 shares of Company stock on March 1, 2022 at prices ranging from $608.30 to $608.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $609.18 to $609.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $610.68 to $610.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F6 Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $611.00 to $611.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F7 Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $612.08 to $612.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F8 Represents volume-weighted average price of sales of 4 shares of Company stock on March 1, 2022 at prices ranging from $614.10 to $614.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F9 Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $615.39 to $615.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F10 Represents volume-weighted average price of sales of 7 shares of Company stock on March 1, 2022 at prices ranging from $616.18 to $616.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F11 Represents volume-weighted average price of sales of 9 shares of Company stock on March 1, 2022 at prices ranging from $617.16 to $617.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F12 Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $618.24 to $618.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F13 Represents volume-weighted average price of sales of 7 shares of Company stock on March 1, 2022 at prices ranging from $619.07 to $619.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F14 Represents volume-weighted average price of sales of 6 shares of Company stock on March 1, 2022 at prices ranging from $620.11 to $620.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F15 Represents volume-weighted average price of sales of 8 shares of Company stock on March 1, 2022 at prices ranging from $621.36 to $621.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F16 Represents volume-weighted average price of sales of 21 shares of Company stock on March 1, 2022 at prices ranging from $622.01 to $622.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
F17 Represents volume-weighted average price of sales of 13 shares of Company stock on March 1, 2022 at prices ranging from $623.00 to $623.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.